PepGen (PEPG) Exchange Rate Effect (2021 - 2026)
PepGen (PEPG) posted Exchange Rate Effect of $3000.0 for Q1 2026, up 400.0% sequentially from -$1000.0 in Q4 2025, and up 142.86% YoY from $1235.3 in Q1 2025.
Powered by 
Analysis
PepGen (PEPG) Exchange Rate Effect (2021 - 2026) Analysis & Trends
PepGen has reported Exchange Rate Effect for 6 years, with the latest figure at $3000.0 in Q1 2026.
- Quarterly Exchange Rate Effect rose 142.86% year-over-year to $3000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6000.0 (changed 0.0% YoY) and the FY2025 annual result came in at -$16000.0, up 74.19% from the prior year.
- Exchange Rate Effect grew to $3000.0 in Q1 2026 per PEPG's latest filing, from -$1000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $241000.0 in Q4 2022 and troughed at -$254000.0 in Q3 2023.
- A 5-year average of -$6176.5 and a median of -$1000.0 in 2025 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 6125.0% in 2022, down 4975.0% in 2022.
- Over 5 years, Exchange Rate Effect stood at $241000.0 in 2022, then slipped by 7.88% to $222000.0 in 2023, then tumbled by 109.91% to -$22000.0 in 2024, then jumped by 95.45% to -$1000.0 in 2025, then soared by 400.0% to $3000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $3000.0, -$1000.0, and $7000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | PepGen | 217.99 Mn | 217.99 Mn | - | 1,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Jun 30, 2025 | -15,000.00 |
| Mar 31, 2025 | -7,000.00 |
| Dec 31, 2024 | -22,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | -63,000.00 |
| Dec 31, 2023 | 222,000.00 |
| Sep 30, 2023 | -254,000.00 |
| Jun 30, 2023 | 194,000.00 |
| Mar 31, 2023 | 124,000.00 |
| Dec 31, 2022 | 241,000.00 |
| Sep 30, 2022 | -217,000.00 |
| Jun 30, 2022 | -203,000.00 |
| Mar 31, 2022 | -137,000.00 |
| Dec 31, 2021 | -4,000.00 |
| Sep 30, 2021 | 17,000.00 |